A cohort study has found that patients with upper tract urothelial carcinoma (UTUC) who had a history of urinary tract stones ...
1. Huang J. Disitamab vedotin plus tislelizumab as nephron-sparing therapy for high-risk upper tract urothelial carcinoma: The phase II DISTINCT-I trial. Presented at: ESMO 2025 Congress; October ...
Patients with urinary stones show poorer survival in upper tract urothelial carcinoma. Find out how stone history may affect ...
ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP ...
Zelenectide pevedotin showed a favorable safety profile and promising antitumor activity in advanced solid tumors, especially ...
The median duration of response was 9.2 months. The combination of atezolizumab and split doses of cisplatin and gemcitabine can produce durable responses in patients with locally advanced or ...
Patients with low-grade upper tract urothelial carcinoma who achieved a complete response after receiving treatment with UGN-101 experienced a clinically meaningful long-term response, with a median ...
Neoadjuvant chemotherapy plus radical cystectomy (NAC-RC) versus trimodality therapy (TMT) in early-stage small cell bladder cancer: Comparison of outcomes. This is an ASCO Meeting Abstract from the ...
CHICAGO —Cabozantinib did not significantly extend progression-free survival in patients with metastatic urothelial carcinoma who had undergone platinum-based chemotherapy, according to data presented ...
Guidelines, Counseling Practices, and Fertility Preservation Options for Childhood Cancer Patients in the Nordic-Baltic Region Urothelial carcinoma (UC) is the most common malignancy of the urinary ...
Urothelium is the term for the mucous membrane that lines the urinary tract. This includes the renal pelvis, ureter, urinary bladder and the upper part of the urethra. In the vast majority of cases, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback